Publication
Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.
Journal Paper/Review - Feb 2, 2022
Frei Nicola Fabian, Stachler Matthew D
Units
PubMed
Doi
Contact
Citation
Type
Journal
Publication Date
Issn Print
Pages
Brief description/objective
A histological diagnosis of dysplasia is our current best predictor of progression in Barrett's esophagus (BE), the precursor of esophageal adenocarcinoma (EAC). Despite periodic endoscopic surveillance and assessment of dysplastic changes, we fail to identify the majority of those who progress before the development of EAC, whereas the majority of patients undergo endoscopy without showing progression.